Waiver Improves Quick Hep C Test Accessibility
OraSure Technologies Inc. receives approval to expand use of rapid hepatitis C test
Published: Tuesday, November 29, 2011
OraSure Technologies Inc. has received a federal waiver that expands access of its rapid hepatitis C test to include doctors offices, clinics and community-based organizations.
Shares rallied 9 percent on the news.
OraSure estimates an additional 180,000 sites nationwide will be able to administer the test, which detects hepatitis C antibodies in about 20 minutes through the company’s OraQuick device.
The test works via finger-stick or on whole blood samples. The Bethlehem diagnostics company makes a similar device to detect HIV.
Continue reading this entire article:
Three Reasons to Be Wary of Recently Publicized Milk Thistle Doubt
Tibotec and Bristol-Myers Team Up to Battle Hepatitis C